Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has ...

GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...

Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of ...

OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...

I was sorry that 23andMe filed for Chapter 11 bankruptcy protection last week, but there would be a blizzard in Death Valley before I would ever use an online DNA kit company. I don't feel comfortable ...

If you suffered losses exceeding $75,000 in GSK between February 5, 2020 and August 14, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...